Home » Newsletters » BioWorld Science

BioWorld Science

March 11, 2010

View Archived Issues

DDP IV inhibitor ASP-4000 has long-lasting effects in preclinical studies

Liposomal amphotericin B is noninferior to conventional therapy in visceral leishmaniasis

Preclinical studies point to potential of NB-003 in treating acne

AG-2 described as new biomarker for ovarian cancer

Albumin therapy to be evaluated in acute ischemic stroke in ongoing phase III trial

AstraZeneca discloses novel JAK2 inhibitors for cancer therapy

GlaxoSmithKline presents new interferon inducers

Merck & Co. describes novel gamma-secretase modulators

NeuroSearch patents new nicotinic acetylcholine alpha7 receptor modulators

Aastrom treats final patient in phase II trial of cardiac repair cells in dilated cardiomyopathy

Lundbeck reports on fourth quarter 2009, ended December 31

Actelion receives FDA's complete response letter on Zavesca sNDA for Niemann-Pick type C disease

Abbott to acquire Facet Biotech

FDA recommends approval InterMune's Esbriet for idiopathic pulmonary fibrosis

FDA approves Botox for upper limb spasticity in adults

Thymosin beta-4 improves neurological outcome in rat model of stroke

Diamyd Medical advances U.S. phase III trial of Diamyd for diabetes type 1

Limerick BioPharma reports positive phase Ia data on LIM-0705

Cempra completes phase I trials of CEM-101 for community-acquired bacterial pneumonia

Cellzome and GSK enter strategic drug discovery alliance in inflammatory disease

Transgene signs exclusive option agreement with Novartis for NSCLC therapeutic TG-4010

FDA grants orphan drug status to Cytokinetics' CK-2017357 in ALS

Affymax receives milestone payment from Takeda for phase III Hematide trial in Japan

ImmunoCellular's CSC-based vaccine ICT-121 increases survival in animal model of glioblastoma

AMT's gene therapy agent for hemophilia B begins phase I/II trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...